Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Chagas Disease
- Atorvastatin on Inflammation and Cardiac Function in Chronic Chagas Disease
- New Scheme for Treatment With Benznidazole
- Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease
- Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC
- New Therapies and Biomarkers for Chagas Infection
- Pharmacokinetic Drug-Drug Interaction Study
- Colchicine for Patients With ChagasĀ“ Disease( B1 Stage)
- Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age
- Oral Fexinidazole Dosing Regimens for the Treatment of Adults With Chronic Indeterminate Chagas Disease
- BENDITA BEnznidazole New Doses Improved Treatment and Associations
- Study Will Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg Tablets Exhibiting Different in Vitro Dissolution Characteristics, and to Evaluate the Relative Bioavailability of Nifurtimox 30 mg and 12
- Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients - Dietary Habits Study
- Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease.
- Prospective Study of a Pediatric Nifurtimox Formulation for Chagas' Disease
- Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients
- Study to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas Disease
- Etiologic Treatment With Benznidazole in Adult Patients With Chronic Chagas Disease. A Randomized Clinical Trial
- CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)
- Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas' Patients
- Population Pharmacokinetics in Benznidazole-treated Adults With Chronic With Chagas Disease
- New Tools for the Diagnosis, Prognosis and Treatment Follow-up in Chagas Disease
- Optimization of PCR Technique to Assess Parasitological Response for Patients With Chronic Chagas Disease
- Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)
- Population Pharmacokinetics Study of Benznidazole in Children With Chagas'Disease
- Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas Disease
- A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267)
- Clinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And Benznidazole
- Selenium Treatment and Chagasic Cardiopathy (STCC)
- Population Pharmacokinetics of Benznidazole in Children With Chagas Disease
- BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease